GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Plag1 | rn6_v1_chr5_-_16799776_16799776 | 0.20 | 4.4e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_198232344 Show fit | 40.83 |
ENSRNOT00000080988
|
aldolase, fructose-bisphosphate A |
|
chr10_+_57278307 Show fit | 38.04 |
ENSRNOT00000005612
|
enolase 3 |
|
chr9_+_81821346 Show fit | 36.53 |
ENSRNOT00000022234
|
phospholipase C, delta 4 |
|
chr1_+_198655742 Show fit | 35.05 |
ENSRNOT00000023944
|
myosin light chain, phosphorylatable, fast skeletal muscle |
|
chr1_-_220136470 Show fit | 34.75 |
ENSRNOT00000026812
|
actinin alpha 3 |
|
chr1_-_215834704 Show fit | 31.82 |
ENSRNOT00000073850
|
insulin-like growth factor 2 |
|
chr1_-_88066101 Show fit | 31.17 |
ENSRNOT00000079473
ENSRNOT00000027893 |
ryanodine receptor 1 |
|
chr1_+_101427195 Show fit | 29.85 |
ENSRNOT00000028271
|
glycogen synthase 1 |
|
chrX_-_78496847 Show fit | 28.28 |
ENSRNOT00000003265
|
integral membrane protein 2A |
|
chr5_+_148528725 Show fit | 26.86 |
ENSRNOT00000017325
|
fatty acid binding protein 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 61.8 | GO:0006000 | fructose metabolic process(GO:0006000) |
17.5 | 52.4 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.5 | 42.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
6.0 | 41.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.9 | 34.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.3 | 33.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
2.2 | 31.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
4.5 | 31.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.7 | 30.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.7 | 29.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 96.3 | GO:0031430 | M band(GO:0031430) |
1.1 | 81.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 57.2 | GO:0005635 | nuclear envelope(GO:0005635) |
0.4 | 39.6 | GO:0030018 | Z disc(GO:0030018) |
6.3 | 38.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
3.1 | 37.7 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 34.9 | GO:0034705 | potassium channel complex(GO:0034705) |
3.4 | 33.7 | GO:0008091 | spectrin(GO:0008091) |
1.1 | 31.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 31.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 102.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 85.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.5 | 82.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 49.0 | GO:0015631 | tubulin binding(GO:0015631) |
2.1 | 47.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 43.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
2.0 | 43.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
5.8 | 40.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
6.3 | 38.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
5.4 | 37.7 | GO:0031014 | troponin T binding(GO:0031014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 50.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 43.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.9 | 34.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.9 | 31.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.2 | 29.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.9 | 27.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.4 | 26.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 24.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 24.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 23.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 110.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.6 | 62.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.0 | 50.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
3.0 | 41.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
1.1 | 39.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 33.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
1.0 | 29.8 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.9 | 28.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 27.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.5 | 21.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |